Improving the quality of life in Arizona to benefit future generations.
As its research infrastructure matures, Arizona is gradually expanding its capacity to conduct clinical trails of new drugs, medical devices, and procedures. The latest signals of the state's progress include two clinical trials ready to kick off, plus the opening of a new clinical-trials center at Arizona State University.
Nine months into her first term, U.S. Rep. Gabrielle Giffords of Tucson has had her first bill signed into law, a professional milestone that is also a boon to the Tucson-based Critical Path Institute. The bill authorizes expanded public-private collaborations toward quicker and safer drug development.